Empresa Pardes Biosciences, Inc.
Acciones
PRDS
US69945Q1058
Biotecnología e investigación médica
Resumen de negocios
Número de empleados: 57
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
James Tananbaum
CEO | Chief Executive Officer | 60 | 01/01/21 |
Dennis Ryan
DFI | Director of Finance/CFO | 69 | 30/08/23 |
Chief Operating Officer | - | - | |
Ann D. Kwong
CTO | Chief Tech/Sci/R&D Officer | - | - |
Patrick O’Brien
IRC | Investor Relations Contact | - | - |
Dave Kuo
HRO | Human Resources Officer | - | - |
Sean P. Brusky
PRN | Corporate Officer/Principal | 47 | 01/05/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
James Tananbaum
CEO | Chief Executive Officer | 60 | 01/01/21 |
Dennis Ryan
DFI | Director of Finance/CFO | 69 | 30/08/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 63 331 613 | 36 906 514 ( 58,28 %) | 1 319 857 ( 2,084 %) | 58,28 % |
Información de la empresa
Pardes Biosciences, Inc.
2173 Salk Avenue Suite 250
92008, Carlsbad
+
![Dirección Pardes Biosciences, Inc.(PRDS)](https://cdn.zonebourse.com/static/address/131203376.png)
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+38,36 % | 52,5 mil M | |
+36,73 % | 39,31 mil M | |
-8,63 % | 39,01 mil M | |
+25,46 % | 28,2 mil M | |
-11,17 % | 26,57 mil M | |
+11,44 % | 26,2 mil M | |
+45,09 % | 14,15 mil M | |
+32,93 % | 12,62 mil M | |
-5,30 % | 11,74 mil M |